Clinical trial
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
NCT00465803 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00465803 |
|---|---|
| Title | A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension |
| Official title | Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Open-angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Travoprost 0.004%/timolol 0.5% ophthalmic solution, Travoprost ophthalmic solution, 0.004%, Timolol maleate ophthalmic solution, 0.5% |
| Enrollment | 81 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2009 |
| First posted | Apr 25, 2007 |
| Last update posted | Jul 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: